KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Exact Sciences (EXAS) Shares Issued (2016 - 2025)

Exact Sciences has reported Shares Issued over the past 16 years, most recently at $10.5 million for Q4 2025.

  • Quarterly Shares Issued rose 159.21% to $10.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.2 million through Dec 2025, down 25.89% year-over-year, with the annual reading at $26.5 million for FY2025, 1507.75% up from the prior year.
  • Shares Issued was $10.5 million for Q4 2025 at Exact Sciences, up from -$17.8 million in the prior quarter.
  • Over five years, Shares Issued peaked at $15.4 million in Q2 2023 and troughed at -$17.8 million in Q4 2024.
  • The 5-year median for Shares Issued is $2.9 million (2021), against an average of $3.2 million.
  • The largest YoY upside for Shares Issued was 2395.01% in 2022 against a maximum downside of 475.36% in 2022.
  • A 5-year view of Shares Issued shows it stood at $2.4 million in 2021, then tumbled by 475.36% to -$9.0 million in 2022, then skyrocketed by 233.26% to $12.0 million in 2023, then tumbled by 247.92% to -$17.8 million in 2024, then skyrocketed by 159.21% to $10.5 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Shares Issued are $10.5 million (Q4 2025), -$17.8 million (Q4 2024), and $12.0 million (Q4 2023).